Contineum Therapeutics (CTNM) Metrics: History & Chart

Contineum Therapeutics, Inc.(CTNM)

Biotechnology · San Diego, CA

$12.65-0.07 (-0.55%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Contineum Therapeutics, Inc.

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing of small molecules different therapies for neuroscience, inflammation, and immunology indications in the United States. The company’s lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and chronic pain. It also develops PIPE-307, a novel, small-molecule inhibitor of the muscarinic type 1 receptor for depression and relapse-remitting multiple sclerosis. The company was formerly known as Pipeline Therapeutics, Inc. and changed its name to Contineum Therapeutics, Inc. in November 2023. Contineum Therapeutics, Inc. was incorporated in 2009 and is based in San Diego, California.

San Diego, CA

51 employees

www.contineum-tx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Carmine N. Stengone

View full financials

Third-Party DCF Estimate (FMP)	$2.40
Price Gap vs Third-Party Estimate	-81.15%

7D Total Return	-0.08%
30D Total Return	-23.83%
YTD Total Return	+11.29%
1Y Total Return	+12.07%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+11.29%
2025	-21.98%
2024	N/A
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	+12.01%
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	17.41
PE Ratio Avg TTM	16.90
PE Ratio Avg 3Y	16.90
Current VS TTM Avg	+3.00%
Current VS 3Y Avg	+3.00%
Current VS 5Y Avg	+3.00%

All Metrics

CTNM Valuation Metrics

CTNM Stock Price Metrics

CTNM Dividend Metrics

CTNM Growth Rate Metrics

CTNM Discounted Cash Flow Metrics

CTNM Returns By Period

CTNM Yearly Returns

CTNM Average Annual Returns By Period (CAGR)

CTNM Revenue Metrics

CTNM PE Ratio Metrics

CTNM PS Ratio Metrics

CTNM PB Ratio Metrics

CTNM Price to Free Cash Flow Ratio Metrics

CTNM Debt to Equity Ratio Metrics

CTNM PEG Ratio Metrics

CTNM FCF Yield

CTNM Earnings Yield

CTNM EBITDA Yield

CTNM OCF Yield

CTNM EV/EBIT Ratio Metrics

CTNM EV/EBITDA Ratio Metrics

CTNM EV/Assets Ratio Metrics

CTNM EV/Sales Ratio Metrics

CTNM Current Ratio Metrics

CTNM Quick Ratio Metrics

CTNM ROIC Metrics

CTNM Return on Assets Metrics

CTNM Return on Equity Metrics

CTNM Net Profit Margin Metrics

CTNM Gross Profit Margin Metrics

CTNM Tax Rate Metrics

PS Ratio	8.89
PS Ratio Avg TTM	8.89
PS Ratio Avg 3Y	8.89
Current VS TTM Avg	-0.03%
Current VS 3Y Avg	-0.03%
Current VS 5Y Avg	-0.03%

PB Ratio	1.99
PB Ratio Avg TTM	1.96
PB Ratio Avg 3Y	1.62
Current VS TTM Avg	+1.75%
Current VS 3Y Avg	+22.72%
Current VS 5Y Avg	+22.72%

PFCF Ratio	27.59
PFCF Ratio Avg TTM	26.42
PFCF Ratio Avg 3Y	26.42
Current VS TTM Avg	+4.42%
Current VS 3Y Avg	+4.42%
Current VS 5Y Avg	+4.42%

Debt/Equity Ratio	0.03
Debt/Equity Ratio Avg TTM	0.03
Debt/Equity Ratio Avg 3Y	0.02
Current VS TTM Avg	-9.07%
Current VS 3Y Avg	+24.36%
Current VS 5Y Avg	+36.80%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	3.62%
FCF Yield Avg TTM	3.93%
FCF Yield Avg 3Y	3.93%
Current VS TTM Avg	-7.94%
Current VS 3Y Avg	-7.94%
Current VS 5Y Avg	-7.94%

Earnings Yield	5.74%
Earnings Yield Avg TTM	6.10%
Earnings Yield Avg 3Y	6.10%
Current VS TTM Avg	-5.91%
Current VS 3Y Avg	-5.91%
Current VS 5Y Avg	-5.91%

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	10.39
Ev/Ebit Ratio Avg TTM	5.92
Ev/Ebit Ratio Avg 3Y	17.76
Current VS TTM Avg	+75.39%
Current VS 3Y Avg	-41.49%
Current VS 5Y Avg	-41.49%

Ev/Ebitda Ratio	10.29
Ev/Ebitda Ratio Avg TTM	5.88
Ev/Ebitda Ratio Avg 3Y	17.52
Current VS TTM Avg	+75.14%
Current VS 3Y Avg	-41.26%
Current VS 5Y Avg	-41.26%

Ev/Assets Ratio	1.87
Ev/Assets Ratio Avg TTM	1.73
Ev/Assets Ratio Avg 3Y	1.40
Current VS TTM Avg	+8.27%
Current VS 3Y Avg	+33.56%
Current VS 5Y Avg	+33.56%

Ev/Sales Ratio	12.43
Ev/Sales Ratio Avg TTM	12.44
Ev/Sales Ratio Avg 3Y	12.44
Current VS TTM Avg	-0.05%
Current VS 3Y Avg	-0.05%
Current VS 5Y Avg	-0.05%

Current Ratio	37.17
Current Ratio Avg TTM	31.25
Current Ratio Avg 3Y	27.34
Current VS TTM Avg	+18.95%
Current VS 3Y Avg	+35.97%
Current VS 5Y Avg	+71.83%

Quick Ratio	37.17
Quick Ratio Avg TTM	31.25
Quick Ratio Avg 3Y	27.34
Current VS TTM Avg	+18.95%
Current VS 3Y Avg	+35.97%
Current VS 5Y Avg	+71.83%

ROIC	(27.22%)
ROIC Avg 3Y	0.49%
ROIC Avg 5Y	0.49%
Current VS 3Y Avg	-5610.88%
Current VS 5Y Avg	-5610.88%
Current VS 10Y Avg	-5610.88%

ROA	(22.99%)
ROA Avg TTM	(6.51%)
ROA Avg 3Y	(6.13%)
Current VS TTM Avg	-253.30%
Current VS 3Y Avg	-275.18%
Current VS 5Y Avg	-275.18%

ROE	(24.02%)
ROE Avg TTM	(27.29%)
ROE Avg 3Y	(24.01%)
Current VS TTM Avg	+11.99%
Current VS 3Y Avg	-0.04%
Current VS 5Y Avg	-0.04%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	1.72%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A